| |
| |
|
| Insider
Information: |
Huang Jane |
| Relationship: |
|
| City: |
Camana Bay, Grand Cayman |
| State: |
E9 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
211,342 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$24,688,484 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
211,342 |
|
|
| Total
Value |
$24,688,484 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
6
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -163.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Beigene Ltd |
BGNE |
CMO, Hematology |
2021-12-14 |
160,055 |
2017-12-04 |
0 |
Premium* |
|
|
Prelude Therapeutics Inc |
PRLD |
|
2024-04-04 |
51,287 |
2023-04-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2016-09-02 |
4 |
A |
$0.00 |
$0 |
D/D |
300,000 |
300,000 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2019-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
62,842 |
334,463 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2020-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
48,438 |
331,902 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2018-06-26 |
4 |
A |
$0.00 |
$0 |
D/D |
44,564 |
309,464 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
President, CMO |
• – – |
2023-04-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
37,500 |
37,500 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2019-11-04 |
4 |
AS |
$189.08 |
$6,266,007 |
D/D |
(32,900) |
0 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2019-11-04 |
4 |
OE |
$29.49 |
$970,221 |
D/D |
32,900 |
32,900 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
25,350 |
304,186 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-07-15 |
4 |
OE |
$119.96 |
$3,085,002 |
D/D |
21,000 |
21,000 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-07-15 |
4 |
AS |
$330.53 |
$6,980,771 |
D/D |
(21,000) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
14,820 |
160,055 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2019-04-08 |
4 |
OE |
$29.49 |
$416,694 |
D/D |
14,130 |
14,130 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2019-04-08 |
4 |
AS |
$140.49 |
$2,017,315 |
D/D |
(14,130) |
0 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
President, CMO |
• – – |
2023-04-06 |
4 |
S |
$6.12 |
$81,274 |
D/D |
(13,280) |
24,220 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-09-13 |
4 |
AS |
$355.37 |
$4,620,390 |
D/D |
(12,901) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2019-07-29 |
4 |
AS |
$132.83 |
$1,362,896 |
D/D |
(10,130) |
0 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2019-07-29 |
4 |
OE |
$29.49 |
$377,834 |
D/D |
10,130 |
10,130 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
President, CMO |
• – – |
2023-07-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,375 |
33,595 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
President, CMO |
• – – |
2023-10-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,375 |
39,728 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
President, CMO |
• – – |
2024-01-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,375 |
49,103 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
President, CMO |
• – – |
2024-04-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,375 |
54,634 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
7,189 |
292,772 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
7,163 |
305,824 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-09-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,124 |
312,948 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-09-20 |
4 |
OE |
$119.96 |
$719,760 |
D/D |
6,000 |
6,000 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
